Prostate Biopsy in Singapore: What to Expect During the Procedure
Learn about prostate biopsy procedures in Singapore, including preparation, techniques, recovery, an
Types of Prostate Biopsy: Which One Is Right for You?
When prostate cancer is suspected due to elevated Prostate-Specific Antigen (PSA) levels or abnormal physical examination findings, a biopsy is the definitive next step required to confirm a diagnosis. However, not all prostate biopsies are the same. Modern urology offers several sophisticated techniques, including the traditional Transrectal Ultrasound-Guided (TRUS) Biopsy, Transperineal Biopsy, MRI-Fusion Biopsy, and Saturation Biopsy. Understanding the differences between these methods, from the procedure itself to recovery expectations, is crucial for patients as your urologist determines the most appropriate, safe, and accurate approach for your specific health profile and diagnostic needs.
Transrectal Ultrasound-Guided Biopsy (TRUS)
TRUS biopsy accesses the prostate through the rectal wall using ultrasound guidance. The urologist typically inserts an ultrasound probe into the rectum to visualise the prostate, then passes a spring-loaded needle through the probe to collect 12-18 tissue cores from predetermined locations across the prostate.
The procedure may take 15-20 minutes under local anaesthesia. The urologist injects lidocaine around the prostate nerves to minimise discomfort. The biopsy gun produces a clicking sound as it rapidly advances and retracts, collecting a tissue sample approximately 1.5 cm long and 1 mm wide.
TRUS remains widely available and requires no specialised MRI equipment. Urologists typically use systematic sampling patterns that divide the prostate into zones, ensuring representative tissue from all areas. This approach may be considered when PSA elevations show no focal abnormalities on MRI, or when MRI is unavailable or contraindicated.
The rectal approach may carry infection risks because the needle passes through bowel bacteria. Some patients may develop infections despite antibiotic prophylaxis. Patients typically receive fluoroquinolone antibiotics starting the day before the procedure, but increasing antibiotic resistance has raised concerns about this protocol.
Blood in urine or stool occurs commonly for 2-3 days after TRUS biopsy. Semen may appear blood-tinged for several weeks. These symptoms resolve without intervention, but can cause anxiety if unexpected.
Transperineal Biopsy
Transperineal biopsy approaches the prostate through the perineum, or the skin between the scrotum and anus. The urologist creates a template grid on the perineal skin, using coordinates to guide needle placement. This method avoids passing needles through the rectum, eliminating contact with bowel bacteria.
Transperineal biopsy has lower infection rates because the needle path remains sterile. This advantage has made transperineal an approach used in many urology practices, particularly for patients at higher risk of infection or those with prior TRUS biopsy infections.
The procedure requires either general anaesthesia or spinal anaesthesia because multiple needle passes through the perineum cause more discomfort than transrectal access. Your urologist positions you in the lithotomy position (legs elevated in stirrups) and places an ultrasound probe in the rectum for prostate visualisation while accessing from below.
Template-based transperineal biopsies sample the prostate more thoroughly than standard TRUS. Urologists can access anterior prostate regions through the perineum, areas where TRUS often misses cancers. The systematic grid pattern ensures even distribution of samples across the entire gland.
Some patients experience urinary retention after transperineal biopsy due to prostatic swelling. Your urologist may insert a temporary catheter for 24-48 hours if you cannot urinate after the procedure. This complication resolves as inflammation subsides.
MRI-Fusion Biopsy
MRI-fusion biopsy combines pre-procedure MRI imaging with real-time ultrasound during the biopsy. Suspicious areas identified on MRI receive targeted sampling in addition to systematic cores from the rest of the prostate. This approach usually detects clinically significant cancers more reliably than systematic sampling alone.
Your urologist reviews your multiparametric MRI before the biopsy and identifies lesions, which are scored using the PI-RADS (Prostate Imaging-Reporting and Data System) system. PI-RADS scores of 4 or 5 indicate high suspicion for cancer and require targeted biopsies. The MRI images are registered with real-time ultrasound during the procedure, creating a fusion image that guides needle placement to suspicious regions.
MRI-fusion can use either transrectal or transperineal access. The targeting capability remains the same regardless of approach, though transperineal MRI-fusion offers both improved anterior sampling and lower infection risk.
MRI fusion can improve the detection of Gleason score seven or higher cancers compared with systematic TRUS biopsy. MRI-fusion reduces the detection of low-grade Gleason 6 cancers that rarely require treatment, helping avoid overdiagnosis.
The procedure typically samples 2-4 cores from each MRI-visible lesion, plus 12 systematic cores from the rest of the prostate. This combined approach ensures that cancers that are invisible on MRI but are present in other areas are still detected.
💡 Did You Know?
MRI-fusion biopsy can be performed as a second biopsy even if your first TRUS biopsy was negative. The MRI targeting often reveals cancers missed by systematic sampling, particularly in the anterior prostate.
Saturation Biopsy
Saturation biopsy collects 20-40 or more tissue cores, far exceeding the 12-18 cores of standard biopsies. Urologists reserve this intensive sampling for specific situations:
- Persistently elevated PSA after multiple negative biopsies
- When clinical suspicion remains high despite previous negative results
The procedure requires general or spinal anaesthesia due to the number of samples taken. A urologist uses a transperineal template approach to systematically map the entire prostate, taking cores at 5-mm intervals throughout the gland.
This method increases cancer detection in patients with previous negative biopsies. Small cancer foci or anterior tumours missed by standard sampling are often detected by saturation biopsy. However, extensive sampling also increases the detection of low-volume, insignificant cancers.
Recovery takes longer after a saturation biopsy. Urinary symptoms, including frequency, urgency, and difficulty starting urination, may persist for 1-2 weeks. Blood in urine and semen lasts longer than with standard biopsies due to the increased tissue trauma.
A urologist considers saturation biopsy when PSA remains elevated despite two negative TRUS biopsies, or when PSA velocity increases rapidly without an identified cause. MRI-fusion has reduced the need for saturation biopsies by enabling targeted sampling of suspicious areas, but saturation remains valuable when MRI shows no lesions despite strong clinical indicators.
How Your Urologist Selects the Right Type
Several clinical factors guide the choice of biopsy method:
- First-time biopsies with PSA between 4-10 ng/mL and suspicious DRE findings typically proceed with standard TRUS or transperineal biopsy, depending on your urologist’s preference and infection risk assessment
- When MRI reveals PI-RADS 4 or 5 lesions, MRI-fusion biopsy becomes an appropriate approach
- Targeted sampling improves the detection of clinically significant cancers while avoiding unnecessary cores in low-suspicion areas.
- Previous biopsy results influence method selection.
- A second biopsy after initial negative results but persistently elevated PSA often uses MRI fusion to investigate areas that may have been missed by systematic sampling.
- Three or more negative biopsies with ongoing suspicion may warrant a saturation biopsy, though MRI typically precedes this decision.
Your medical history affects approach selection. Patients with previous prostate infections, current anticoagulation therapy, require careful timing of medication adjustments and may prefer transperineal approaches for better haemostasis control.
Prostate size influences the number of cores needed. Glands larger than 50 grams often require additional systematic cores to maintain adequate sampling density, while smaller prostates may need fewer cores for thorough assessment.
What to Expect During Each Procedure
All prostate biopsies follow similar preparation protocols. You’ll take antibiotics starting the day before and continue for 2-3 days after. Enemas clean the rectum before transrectal approaches. Blood-thinning medications require temporary discontinuation based on your urologist’s recommendations.
TRUS biopsies occur in the clinic under local anaesthesia. You lie on your left side while the urologist performs DRE, inserts the ultrasound probe, and injects local anaesthetic. The actual sampling takes 5-10 minutes, with each core producing a brief pinching sensation.
Transperineal and MRI-fusion procedures typically occur in an operating theatre or procedure suite. After anaesthesia takes effect, positioning and equipment setup require 10-15 minutes before sampling begins. The biopsy itself takes 15-30 minutes, depending on the number of cores planned.
Saturation biopsies last 30-45 minutes due to the extensive sampling required. The longer procedure time necessitates general anaesthesia to ensure patient comfort and prevent movement during template-guided sampling.
⚠️ Important Note
Inform your urologist about all medications, particularly antiplatelet drugs like aspirin or clopidogrel. These require appropriate timing for discontinuation and resumption to balance bleeding risk against cardiovascular protection.
Recovery and Results Timeline
Recovery patterns differ between approaches. TRUS biopsy patients usually resume normal activities the next day, avoiding strenuous exercise for 48 hours. Transperineal and MRI-fusion biopsies require 2-3 days of reduced activity, during which perineal discomfort improves gradually.
Urinary symptoms peak on day 2-3 after any biopsy type. Frequency, urgency, and mild burning during urination typically resolve within one week. Persistent symptoms beyond 5 days warrant contact with your urologist.
Blood in urine usually clears within 3-5 days but may appear intermittently for up to two weeks. Haematospermia (blood in semen) persists longer, often visible for 4-8 weeks or up to 10 ejaculations. This causes no harm and requires no treatment.
Pathology results may become available 5-7 working days after the biopsy. Your urologist reviews the report to determine whether cancer was found and, if so, the Gleason score, the number of positive cores, the percentage of cancer in each core, and the presence of perineural invasion. These factors can collectively determine cancer risk stratification and treatment recommendations.
Negative biopsy results don’t always eliminate cancer concern. Your urologist interprets negative findings in context with PSA trends, DRE findings, and MRI results. PSA monitoring continues, with repeat biopsy considered if concerning changes develop.
Putting This Into Practice
- Schedule your biopsy during a period when you can arrange 2-3 days of light activity afterwards, avoiding heavy lifting, prolonged sitting, or intense exercise during initial recovery.
- Prepare a list of all medications, including over-the-counter supplements, for your pre-procedure consultation, as some herbal products affect bleeding risk even if not traditionally classified as blood thinners.
- Arrange transportation home after the procedure, particularly for transperineal, MRI-fusion, or saturation biopsies performed under general or spinal anaesthesia that temporarily impair driving ability.
- Keep your urologist’s contact information readily accessible during the first week after biopsy to report any fever above 38°C, inability to urinate, or heavy bleeding that doesn’t improve with rest.
When to Seek Professional Help
Contact your urologist if you experience:
- Fever above 38°C with chills
- Inability to pass urine for more than 6 hours
- Heavy rectal bleeding requiring more than two pad changes per hour
- Severe perineal pain unrelieved by prescribed pain medication
- Dizziness or lightheadedness suggesting significant blood loss
- Urinary symptoms are worsening after day 3 instead of improving
Commonly Asked Questions
How painful is a prostate biopsy?
TRUS biopsy under local anaesthesia causes brief discomfort with each core—patients describe a sharp pinch or stinging lasting 1-2 seconds. Transperineal and MRI-fusion procedures use general or spinal anaesthesia, eliminating pain during the procedure. Post-procedure soreness feels like bruising and responds well to paracetamol.
Can I go to work the day after my biopsy?
After a TRUS biopsy, many patients return to desk work the next day if they are feeling well. Transperineal approaches benefit from an additional recovery day due to perineal discomfort when sitting. Avoid jobs requiring heavy lifting or significant physical exertion for 3-5 days after any biopsy type.
Will I need a catheter after the biopsy?
Catheters are rarely needed after a TRUS biopsy. Transperineal biopsies sometimes require temporary catheterisation due to prostatic swelling. Your urologist removes the catheter after 24-48 hours once swelling subsides and normal urination resumes.
What happens if my biopsy is negative but PSA stays high?
Your urologist monitors PSA every 3-6 months after a negative biopsy. Rising PSA despite negative results may prompt MRI if not previously performed, or consideration of a repeat biopsy using a different method. Some men have benign conditions causing elevated PSA, including prostatitis or benign prostatic hyperplasia, requiring different management approaches.
How accurate are prostate biopsies at detecting cancer?
TRUS biopsy detects most cancers. MRI-fusion increases the detection of clinically significant disease. No biopsy method achieves 100% sensitivity, which is why urologists continue to monitor PSA and symptoms even after negative results.
Conclusion
Understanding the differences between TRUS, transperineal, MRI-fusion, and saturation biopsies helps you make informed decisions about prostate cancer screening. MRI-fusion may offer the highest accuracy for detecting significant cancers, while transperineal approaches provide lower infection risk. Your individual risk factors and PSA history guide the optimal choice.
If you are experiencing elevated PSA levels, abnormal digital rectal examination findings, or need a repeat biopsy after previous negative results, Dr Tan Teck Wei can evaluate your specific situation and recommend the most appropriate biopsy approach.
